Transfer of Treasury Shares

AI SummaryClose X

On 20 November 2026 GSK transferred 22,000,000 treasury Ordinary Shares to JPMorgan to procure issuance of 11,000,000 ADRs at $47.82 per ADR (equivalent to $23.91 per Ordinary Share), funded by a contribution from GlaxoSmithKline LLC, to satisfy awards under the Deferred Annual Bonus Plan, Performance Share Plan and Share Value Plan; post-transfer the Company holds 248,881,064 Ordinary Shares in treasury and has 4,067,451,066 Ordinary Shares in issue (total voting rights 4,067,451,066), with Treasury Shares representing 6.12% of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings